Literature DB >> 26928707

Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Shuji Ogino1, Reiko Nishihara, Tyler J VanderWeele, Molin Wang, Akihiro Nishi, Paul Lochhead, Zhi Rong Qian, Xuehong Zhang, Kana Wu, Hongmei Nan, Kazuki Yoshida, Danny A Milner, Andrew T Chan, Alison E Field, Carlos A Camargo, Michelle A Williams, Edward L Giovannucci.   

Abstract

Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases, such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical/radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational/systems biology, there are wide open opportunities in MPE to contribute to public health.

Entities:  

Mesh:

Year:  2016        PMID: 26928707      PMCID: PMC4892980          DOI: 10.1097/EDE.0000000000000471

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  95 in total

1.  Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.

Authors:  Daniel J Weisenberger; A Joan Levine; Tiffany I Long; Daniel D Buchanan; Rhiannon Walters; Mark Clendenning; Christophe Rosty; Amit D Joshi; Mariana C Stern; Loic LeMarchand; Noralane M Lindor; Darshana Daftary; Steven Gallinger; Teresa Selander; Bharati Bapat; Polly A Newcomb; Peter T Campbell; Graham Casey; Dennis J Ahnen; John A Baron; Robert W Haile; John L Hopper; Joanne P Young; Peter W Laird; Kimberly D Siegmund
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-13       Impact factor: 4.254

2.  NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

Authors:  Phillip G Febbo; Marc Ladanyi; Kenneth D Aldape; Angelo M De Marzo; M Elizabeth Hammond; Daniel F Hayes; A John Iafrate; R Kate Kelley; Guido Marcucci; Shuji Ogino; William Pao; Dennis C Sgroi; Marian L Birkeland
Journal:  J Natl Compr Canc Netw       Date:  2011-11       Impact factor: 11.908

3.  Serrated lesions of the colorectum: review and recommendations from an expert panel.

Authors:  Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church
Journal:  Am J Gastroenterol       Date:  2012-06-19       Impact factor: 10.864

4.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.

Authors:  Mingyang Song; Reiko Nishihara; Molin Wang; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Kana Wu; Shuji Ogino; Zhi Rong Qian; Kentaro Inamura; Xuehong Zhang; Kimmie Ng; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Katsuhiko Nosho
Journal:  Gut       Date:  2015-01-15       Impact factor: 23.059

5.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

Authors:  Clare Abbenhardt; Elizabeth M Poole; Richard J Kulmacz; Liren Xiao; Karen Curtin; Rachel L Galbraith; David Duggan; Li Hsu; Karen W Makar; Bette J Caan; Lisel Koepl; Robert W Owen; Dominique Scherer; Christopher S Carlson; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

6.  Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features.

Authors:  Christophe Rosty; Joanne P Young; Michael D Walsh; Mark Clendenning; Rhiannon J Walters; Sally Pearson; Erika Pavluk; Belinda Nagler; David Pakenas; Jeremy R Jass; Mark A Jenkins; Aung Ko Win; Melissa C Southey; Susan Parry; John L Hopper; Graham G Giles; Elizabeth Williamson; Dallas R English; Daniel D Buchanan
Journal:  Mod Pathol       Date:  2013-01-25       Impact factor: 7.842

7.  Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women.

Authors:  Paul J Limburg; David Limsui; Robert A Vierkant; Lori S Tillmans; Alice H Wang; Charles F Lynch; Kristin E Anderson; Amy J French; Robert W Haile; Lisa J Harnack; John D Potter; Susan L Slager; Thomas C Smyrk; Stephen N Thibodeau; James R Cerhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-15       Impact factor: 4.254

8.  Body size, physical activity, early-life energy restriction, and associations with methylated insulin-like growth factor-binding protein genes in colorectal cancer.

Authors:  Colinda C J M Simons; Piet A van den Brandt; Coen D A Stehouwer; Manon van Engeland; Matty P Weijenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-27       Impact factor: 4.254

Review 9.  Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review.

Authors:  Łukasz Szylberg; Marlena Janiczek; Aneta Popiel; Andrzej Marszałek
Journal:  Gastroenterol Res Pract       Date:  2015-04-07       Impact factor: 2.260

10.  Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype.

Authors:  Y Zhu; S R Yang; P P Wang; S Savas; T Wish; J Zhao; R Green; M Woods; Z Sun; B Roebothan; J Squires; S Buehler; E Dicks; J Zhao; J R Mclaughlin; P S Parfrey; P T Campbell
Journal:  Br J Cancer       Date:  2014-01-21       Impact factor: 7.640

View more
  93 in total

1.  The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure.

Authors:  Daniel Nevo; Reiko Nishihara; Shuji Ogino; Molin Wang
Journal:  Lifetime Data Anal       Date:  2017-08-04       Impact factor: 1.588

2.  Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.

Authors:  NaNa Keum; Chen Yuan; Reiko Nishihara; Emilie Zoltick; Tsuyoshi Hamada; Alejandro Martinez Fernandez; Xuehong Zhang; Akiko Hanyuda; Li Liu; Keisuke Kosumi; Jonathan A Nowak; Iny Jhun; T Rinda Soong; Teppei Morikawa; Fred K Tabung; Zhi Rong Qian; Charles S Fuchs; Jeffrey A Meyerhardt; Andrew T Chan; Kimmie Ng; Shuji Ogino; Edward L Giovannucci; Kana Wu
Journal:  Int J Cancer       Date:  2017-03-28       Impact factor: 7.396

3.  Calcium intake and colon cancer risk subtypes by tumor molecular characteristics.

Authors:  NaNa Keum; Li Liu; Tsuyoshi Hamada; Zhi Rong Qian; Jonathan A Nowak; Yin Cao; Annacarolina da Silva; Keisuke Kosumi; Mingyang Song; Daniel Nevo; Molin Wang; Andrew T Chan; Jeffrey A Meyerhardt; Charles S Fuchs; Kana Wu; Shuji Ogino; Reiko Nishihara; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2019-04-08       Impact factor: 2.506

4.  Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.

Authors:  Keisuke Kosumi; Yohei Masugi; Juhong Yang; Zhi Rong Qian; Sun A Kim; Wanwan Li; Yan Shi; Annacarolina da Silva; Tsuyoshi Hamada; Li Liu; Mancang Gu; Tyler S Twombly; Yin Cao; David A Barbie; Katsuhiko Nosho; Hideo Baba; Wendy S Garrett; Jeffery A Meyerhardt; Edward L Giovannucci; Andrew T Chan; Charles S Fuchs; Shuji Ogino; Reiko Nishihara
Journal:  Oncoimmunology       Date:  2017-01-31       Impact factor: 8.110

5.  Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.

Authors:  Tsuyoshi Hamada; Yin Cao; Zhi Rong Qian; Yohei Masugi; Jonathan A Nowak; Juhong Yang; Mingyang Song; Kosuke Mima; Keisuke Kosumi; Li Liu; Yan Shi; Annacarolina da Silva; Mancang Gu; Wanwan Li; NaNa Keum; Xuehong Zhang; Kana Wu; Jeffrey A Meyerhardt; Edward L Giovannucci; Marios Giannakis; Scott J Rodig; Gordon J Freeman; Daniel Nevo; Molin Wang; Andrew T Chan; Charles S Fuchs; Reiko Nishihara; Shuji Ogino
Journal:  J Clin Oncol       Date:  2017-04-13       Impact factor: 44.544

Review 6.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

7.  Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status.

Authors:  Akiko Hanyuda; Yin Cao; Tsuyoshi Hamada; Jonathan A Nowak; Zhi Rong Qian; Yohei Masugi; Annacarolina da Silva; Li Liu; Keisuke Kosumi; Thing Rinda Soong; Iny Jhun; Kana Wu; Xuehong Zhang; Mingyang Song; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino; Reiko Nishihara
Journal:  Eur J Epidemiol       Date:  2017-05-16       Impact factor: 8.082

8.  Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.

Authors:  Li Liu; Reiko Nishihara; Zhi Rong Qian; Fred K Tabung; Daniel Nevo; Xuehong Zhang; Mingyang Song; Yin Cao; Kosuke Mima; Yohei Masugi; Yan Shi; Annacarolina da Silva; Tyler Twombly; Mancang Gu; Wanwan Li; Tsuyoshi Hamada; Keisuke Kosumi; Kentaro Inamura; Jonathan A Nowak; David A Drew; Paul Lochhead; Katsuhiko Nosho; Kana Wu; Molin Wang; Wendy S Garrett; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino
Journal:  Gastroenterology       Date:  2017-09-01       Impact factor: 22.682

Review 9.  Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Authors:  David G Menter; Jennifer S Davis; Bradley M Broom; Michael J Overman; Jeffrey Morris; Scott Kopetz
Journal:  Curr Gastroenterol Rep       Date:  2019-01-30

10.  Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.

Authors:  Yohei Masugi; Reiko Nishihara; Juhong Yang; Kosuke Mima; Annacarolina da Silva; Yan Shi; Kentaro Inamura; Yin Cao; Mingyang Song; Jonathan A Nowak; Xiaoyun Liao; Katsuhiko Nosho; Andrew T Chan; Marios Giannakis; Adam J Bass; F Stephen Hodi; Gordon J Freeman; Scott Rodig; Charles S Fuchs; Zhi Rong Qian; Shuji Ogino
Journal:  Gut       Date:  2016-05-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.